Possible inhibitory roles of endogenous 2-arachidonoylglycerol during corticotropin-releasing factor-induced activation of central sympatho-adrenomedullary outflow in anesthetized rats

European Journal of Pharmacology

Volumn 641, Issue 1, 2010, Pages 54-60

  Shimizu, Takahiro ^a   Lu, Lianyi ^a   Yokotani, Kunihiko ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

2 Arachidonoylglycerol; Brain; Cannabinoid CB1 receptor; Corticotropin releasing factor; Monoacylglycerol lipase; Sympatho adrenomedullary outflow

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ADRENALIN; CANNABINOID 1 RECEPTOR AGONIST; CORTICOTROPIN RELEASING FACTOR; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NORADRENALIN; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL-2-CHLOROETHYLAMIDE; CANNABINOID RECEPTOR AFFECTING AGENT; CANNABINOID RECEPTOR AGONIST; CATECHOLAMINE; ENDOCANNABINOID; N-(4-HYDROXYPHENYL)ARACHIDONYLAMIDE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; INHIBITION KINETICS; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; ANESTHESIA; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BRAIN; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ADRENAL MEDULLA; ANESTHESIA; ANIMALS; ARACHIDONIC ACIDS; BRAIN; CATECHOLAMINES; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; GLYCERIDES; MALE; MONOACYLGLYCEROL LIPASES; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; SYMPATHETIC NERVOUS SYSTEM; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR MODULATORS;

EID: 77953810136     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.007     Document Type: Article

References (49)

1. Anton A.H., Sayre D.F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 1962, 138:360-375.
2. Bell R.L., Kennerly D.A., Stanford N., Majerus P.W. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc. Natl Acad. Sci. USA 1979, 76:3238-3241.
3. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997, 277:1094-1097.
4. Bisogno T. Endogenous cannabinoids: structure and metabolism. J. Neuroendocrinol. 2008, 20:1-9.
5. Bisogno T., MacCarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agrò A., Hillard C., Di Marzo V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 2001, 268:1982-1989.
6. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 2003, 163:463-468.
7. Blankman J.L., Simon G.M., Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14:1347-1356.
8. Brozoski D.T., Dean C., Hopp F.A., Seagard J.L. Uptake blockade of endocannabinoids in the NTS modulates baroreflex-evoked sympathoinhibition. Brain Res. 2005, 1059:197-202.
9. Centonze D., Finazzi-Agrò A., Bernardi G., Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 2007, 28:180-187.
10. Di Marzo V. A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists. Trends Pharmacol. Sci. 2006, 27:134-140.
11. Di Marzo V., Ligresti A., Cristino L. The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation. Int. J. Obes. 2009, 33:S18-S24.
12. Di S., Boudaba C., Popescu I.R., Weng F.J., Harris C., Marcheselli V.L., Bazan N.G., Tasker J.G. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J. Physiol. 2005, 569:751-760.
13. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl Acad. Sci. USA 2002, 99:10819-10824.
14. 1 receptors selectively stimulates feeding of palatable foods in rats. J. Neurosci. 2008, 28:9702-9709.
15. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
16. Giuffrida A., Beltramo M., Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 2001, 298:7-14.
17. Goparaju S.K., Ueda N., Taniguchi K., Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 1999, 57:417-423.
18. Heifets B.D., Castillo P.E. Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 2009, 71:283-306.
19. 1). J. Pharmacol. Exp. Ther. 1999, 1999:1427-1433.
20. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
21. Jung K.M., Astarita G., Zhu C., Wallace M., Mackie K., Piomelli D. A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. Mol. Pharmacol. 2007, 72:612-621.
22. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:849-863.
23. 1-receptor agonist, on penicillin-induced epileptiform activity in rats. Epilepsia 2009, 50:1760-1767.
24. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29:717-727.
25. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 1999, 42:769-776.
26. 1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J. Neurosci. 2008, 28:2976-2990.
27. Mackie K. Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol. 2008, 20:10-14.
28. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
29. Moreira F.A., Aguiar D.C., Guimarães F.S. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 2007, 52:958-965.
30. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
31. 2 in the activation of the central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 2002, 452:289-294.
32. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
33. 2 in the release of noradrenaline and adrenaline from adrenal medulla in rats. Eur. J. Pharmacol. 2003, 467:125-131.
34. Okada S., Shimizu T., Yokotani K. Brain phospholipase C and diacylglycerol lipase are involved in corticotropin-releasing hormone-induced sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 2003, 475:49-54.
35. Pacher P., Bátkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006, 58:389-462.
36. 1 receptor activity in rat brain cryosections by functional autoradiography. J. Neurochem. 2007, 101:972-981.
37. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier Academic Press, Burlington. G. Paxinos, C. Watson (Eds.).
38. Quistad G.B., Klintenberg R., Caboni P., Liang S.N., Casida J.E. Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol. Appl. Pharmacol. 2006, 211:78-83.
39. Saario S.M., Savinainen J.R., Laitinen J.T., Jarvinen T., Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem. Pharmacol. 2004, 67:1381-1387.
40. Shimizu T., Yokotani K. Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats. Eur. J. Pharmacol. 2008, 582:62-69.
41. Shimizu T., Okada S., Yamaguchi-Shima N., Yokotani K. Brain phospholipase C-diacylglycerol lipase pathway is involved in vasopressin-induced release of noradrenaline and adrenaline from adrenal medulla in rats. Eur. J. Pharmacol. 2004, 499:99-105.
42. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
43. Sugiura T., Waku K. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids 2000, 108:89-106.
44. Tang X., Edwards E.M., Holmes B.B., Falck J.R., Campbell W.B. Role of phospholipase C and diacylglyceride lipase pathway in arachidonic acid release and acetylcholine-induced vascular relaxation in rabbit aorta. Am. J. Physiol. Heart Cric. Physiol. 2006, 290:H37-H45.
45. Vinod K.Y., Hungund B.L. Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 2006, 27:539-545.
46. Wang Q., Peng Y., Chen S., Gou X., Hu B., Du J., Lu Y., Xiong L. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009, 40:2157-2164.
47. 3 receptors. Br. J. Pharmacol. 1995, 115:672-676.
48. 2-arachidonic acid cascade is involved in the activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 2000, 398:341-347.
49. 1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 2001, 419:183-189.